Evidence map›Paper›PMID 40660162›Full record

ArticleBMC veterinary research2025

Comparative in vitro assessment of oak (Quercus infectoria) and Carob (Ceratonia siliqua) extracts as natural alternatives to metronidazole against Trichomonas gallinae.

Bahaa Ibrahim Saeed, Farnaz Malekifard, Mohammad Yakhchali

Abstract readComparative Study
In one paragraph

Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bahaa Ibrahim SaeedDepartment of Pathobiology, Faculty of Veterinary Medicine, Urmia University, P.O. Box 1177, Urmia, Iran.
Farnaz MalekifardDepartment of Pathobiology, Faculty of Veterinary Medicine, Urmia University, P.O. Box 1177, Urmia, Iran. f.malekifard@urmia.ac.ir.
Mohammad YakhchaliDepartment of Pathobiology, Faculty of Veterinary Medicine, Urmia University, P.O. Box 1177, Urmia, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTrichomonas gallinae, a protozoan parasite, is responsible for avian trichomoniasis, leading to significant morbidity and mortality, particularly among juvenile pigeons. Although metronidazole is the standard treatment, its potential for inducing resistance has prompted exploration of herbal extracts as alternative therapeutic options. This study aims to compare metronidazole's antitrichomonal effects with oak (Quercus infectoria) extracts and carob (Ceratonia siliqua) on T. gallinae in vitro.

methodsT. gallinae samples were collected from infected pigeons. For the in vitro study, multiwell plates were used with different concentrations (5, 10, 25, 50, and 100 µg/mL).

resultsThe minimum inhibitory concentration (MIC) after 24 hr for Q. infectoria was 25 µg/mL, while for C. siliqua it was 50 µg/mL. In comparison, the MIC of metronidazole was also found to be 50 µg/mL.

conclusionsFindings suggest that Q. infectoria and C. siliqua extracts exhibit potent antitrichomonal activity, comparable to metronidazole, in inhibiting T. gallinae trophozoite growth in vitro, making them viable natural alternatives.

Indexed as

Antiprotozoal AgentsAntitrichomonal AgentsGalactansMetronidazolePlant ExtractsPlant GumsQuercusTrichomonasAnimalsBird DiseasesColumbidaeMannansMicrobial Sensitivity TestsTrichomonas InfectionsAntiprotozoal AgentsAntitrichomonal AgentsGalactanslocust bean gumMannansMetronidazolePlant ExtractsPlant GumsCarob (Ceratonia siliqua) extractsIn vitroOak (Quercus infectoria)Trichomonas gallinae

Identifiers

PMID40660162
PMCPMC12257694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.